Gut microbiome characteristics in patients with hormone receptor–positive (HR+) HER2− breast cancer treated with adjuvant abemaciclib: Biomarker analysis of the TRADE trial.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Dana-Farber Cancer Institute, Harvard University
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162541853
Cites:
Cited by:
Related to: